Mubadala invests in India’s Manipal Health Enterprises
IMT News Desk
Temasek, a Singapore-headquartered global investment company, will continue to hold a majority stake in ManipalMubadala Investment Company announced that it is investing in Manipal Health Enterprises (Manipal). Temasek, a Singapore-headquartered global investment company, will continue to hold a majority stake in Manipal.“Manipal is one of India’s leading healthcare networks, distinguishing itself through its commitment to clinical excellence, its strong patient-centric approach, and its impeccable standards of corporate governance,” said Camilla Macapili Languille, Head of Life Sciences, Mubadala. “Given the ever-increasing demand for high-quality hospital care across India, we look forward to supporting Manipal’s growth journey in the years ahead.” “We are delighted to work with such high-quality partners like Temasek, TPG, Dr Ranjan Pai and the management team of Manipal to drive the business through the next phase of its growth trajectory,” said Luca Molinari, Head of Asia, Direct Investments, at Mubadala. “Manipal is playing a central role in developing India’s national healthcare infrastructure and we are tremendously excited to partner with them.”
